SCHEMBL5014041

SCHEMBL5014041

CCOC(=O)c1cc2c(nc(-c3ccccc3)n2-c2ccccc2)s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 2/20 0.54
SIRT1 Q96EB6 2/20 0.54
KDM4E B2RXH2 2/20 0.50
GABRA2 P47869 3/20 0.49
GABRB2 P47870 3/20 0.49
ALDH1A1 P00352 6/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPT P10636 3/20 0.47
GAA P10253 2/20 0.47
CDC7 O00311 1/20 0.44
TRPM8 Q7Z2W7 1/20 0.44
DBF4 Q9UBU7 1/20 0.44
RECQL P46063 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MAPK1 P28482 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TP53 P04637 1/20 0.43
ALOX12 P18054 1/20 0.43
CYP3A4 P08684 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5012193 0.84 MDM2 (0.43) SIRT2SIRT1KDM4EALDH1A1MEN1
SCHEMBL5014038 0.81 OGFRL1 (0.50) KDM4EALDH1A1MAPTGAAMAPK1
SCHEMBL2681081 0.75 GABRA2 (0.58) SIRT2SIRT1KDM4EGABRA2GABRB2
SCHEMBL12135170 0.72 SIRT2 (0.69) SIRT2SIRT1GABRA2GABRB2ALDH1A1
SCHEMBL16474392 0.71 KDM4E (0.55) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL21760759 0.71 SIRT2 (0.74) SIRT2SIRT1GABRA2GABRB2ALDH1A1
SCHEMBL21749185 0.70 SIRT2 (0.61) SIRT2SIRT1GABRA2GABRB2ALDH1A1
SCHEMBL3322113 0.70 HSP90AB1 (0.69) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL27243768 0.69 KDM4E (0.64) KDM4EALDH1A1KMT2AMAPTGAA
SCHEMBL13088494 0.69 HPGD (0.60) KDM4EALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249146-A1 Imidazole and Thioazole Derivatives as Antiviral Agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2008-10-09 US disclosed
EP-1773331-A1 IMIDAZOLE AND THIAZOLE DERIVATIVES AS ANTIVIRAL AGENTS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2007-04-18 EP disclosed
WO-2006008556-A1 IMIDAZOLE AND THIAZOLE DERIVATIVES AS ANTIVIRAL AGENTS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2006-01-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249146-A1 Imidazole and Thioazole Derivatives as Antiviral Agents IRF3, HAVCR2, ZC3HAV1 SIRT2 1638/4885SIRT1 1657/4885KDM4E 2816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.